DISCOVER THE SCIENCE OF CBD

Why Pureis CBD?

Pureis was founded by Chanelle
McCoy and Caroline Coen, both
with extensive pharmaceutical
training and experience.

When they became aware of the many misleading and poor-quality CBD products
on the market, they resolved to develop a safe, certified product for the consumer.
The rest is Pureis history.

Why [Pureis] Lab Made CBD?

CBD can be made in one of two ways:

1. Processing cannabis plants – isolating CBD and
attempting to remove all impurities;

2. Synthesising pure CBD in a laboratory.

It is nearly impossible to extract pure CBD from the cannabis plant. There will always
be traces of other cannabinoids, including THC, the addictive part of cannabis.

Pureis is made by scientists, using citrus fruits to produce pure CBD by mimicking
specific sections of DNA from the cannabis plant. Because there are no impurities to
begin with, there are no impurities in the end product. All you get is completely safe,
Ultra Pure CBD.

*Pureis® Ultra Pure CBD is rigorously tested and backed by safety clinical studies. We commissioned toxicology studies in line with European Food Safety Authority and UK Food Standards Agency (FSA) guidelines for food additive safety assessments. These proprietary studies followed OECD guidelines and GLP principles. Our studies and analytical data led to the UK FSA’s approval of safety, stating that our synthetic CBD, was safe under the proposed conditions of use of a food supplement[i]. Our synthetic CBD contains 0% THC and no impurities commonly found in hemp or cannabis-derived CBD products.

[i] Food Standards Agency. (2021). Safety assessment: Synthetic cannabidiol (CBD) as a novel food for use in food supplements.

https://www.food.gov.uk/research/research-projects/safety-assessment-synthetic-cannabidiol-cbd-as-a-novel-food-for-use-in-food-supplements

**UK Food Standard Agency has precautionary guidance on recommending an Acceptable Daily Intake (ADI) of 10 mg for CBD. Notwithstanding this precautionary advice our toxicology studies confirm CBD use at levels higher than the FSA’s 10 mg guidance. While we support this guideline, our data substantiates CBD use at the higher levels found in some of our products.

A recent consumer user trial involving 113 participants over a 7-day period demonstrated the effectiveness of CBD Muscle & Joint Balm.

These findings, coupled with a clinical product study, solidify CBD Muscle & Joint Balm as a reliable solution for aiding joint mobility and muscle tightness after massaging it into desired area. For more information on product trials, please feel free to contact us at info@pureiscbd.com

@pureiscbd